Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults
NCT ID: NCT02496858
Last Updated: 2019-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2017-05-12
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors of Individuals With Coronary Artery Disease
NCT00260104
Study on Susceptibility Genes and Pathogenic Mechanism of Non-syndromic Familial Aortic Dissection
NCT04439565
Peking University & University of Michigan Study of MI and Atherosclerosis
NCT04950699
Study on Genetically Affected Sporadic Thoracic Aortic Aneurysm and Dissection
NCT02852603
Genetic Markers of Coronary Heart Disease in Type 2 Diabetes
NCT00078052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to investigate the genetic loci, or gene variations contributing to the development and prognosis of CAD in Chinese young adult. Investigators will compare the angiogram results to genetic findings first in patients with different stages of CAD. Then, investigators will collect patients from hospital discharge registry, and compare long-term outcome as well as on operative details in different gene groups.
The results of the study provide a possibility to develop a gene test to recognize patients at risk at its early stage, and needing for preventive medicine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early-onset CAD
The anticipated 2000 young CAD patients who aged ≤45years undergoing coronary angiography will be recruited in the prospective cohort. Medical history and risk-factor information were obtained by interviewing patients and by abstracting information from medical records.
No interventions assigned to this group
Late-onset CAD
The anticipated 2000 old CAD patients aged≥65years undergoing coronary angiography will be recruited in the prospective cohort. Medical history and risk-factor information were obtained by interviewing patients and by abstracting information from medical records.
No interventions assigned to this group
Age-matched controls
The anticipated 2000 control subjects without obvious coronary stenosis aged≤45years or ≥65years will be recruited in the prospective cohort. Medical history and risk-factor information were obtained by interviewing patients and by abstracting information from medical records.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. mature CAD, refers to patients who aged ≥ 65 years and meat the same CAD diagnostic criteria as above;
3. age matched individuals who had coronary arteries without obvious stenosis.
Exclusion Criteria
2. patients with malignancies;
3. pregnant or planning for pregnancy.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Junbo Ge
Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Xiamen Cardiovascular Hospital
Xiamen, Fujian, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Sun yat-sen Memorial Hospital
Guangzhou, Guangdong, China
Zhuhai Hospital of Guangdong Provincial People's Hospital
Zhuhai, Guangdong, China
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Nanning, Guangxi, China
Affiliated Hospital of Zunyi Medical College
Zunyi, Guizhou, China
The second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Wuhan Asia Heart Hospital
Wuhan, Hubei, China
Wuxi Third People's Hospital
Wuxi, Jiangsu, China
Xuzhou Fourth People's Hospital
Xuzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The second Hospital of Jilin University
Changchun, Jilin, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
The First Affiliated Hospital of Xi 'an Jiaotong University
Xi'an, Shaanxi, China
Shanghai Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Central Hospital of Jiading District
Shanghai, Shanghai Municipality, China
Central Hospital of Minhang District
Shanghai, Shanghai Municipality, China
Central Hospital of Yangpu District
Shanghai, Shanghai Municipality, China
Changhai Hospital of Second Military Medical University of Chinese PLA
Shanghai, Shanghai Municipality, China
Shanghai Changzheng Hospital
Shanghai, Shanghai Municipality, China
Shanghai chest hospital
Shanghai, Shanghai Municipality, China
Shanghai First People's Hospital
Shanghai, Shanghai Municipality, China
Shanghai Ninth People's Hospital
Shanghai, Shanghai Municipality, China
Shanghai Shidong Hospital
Shanghai, Shanghai Municipality, China
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China
Shanghai Tongren Hospital
Shanghai, Shanghai Municipality, China
Tenth People's Hospital of Tongji University
Shanghai, Shanghai Municipality, China
Tongji Hospital of Tongji University
Shanghai, Shanghai Municipality, China
Yueyang hospital
Shanghai, Shanghai Municipality, China
Shanxi cardiovascular hospital
Taiyuan, Shanxi, China
Taiyuan central hospital
Taiyuan, Shanxi, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
Karamay Central Hospital
Karamay, Xinjiang, China
Yan'an Hospital of Kunming City
Kunming, Yunnan, China
Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China
Zhenjiang First People's Hospital
Hangzhou, Zhenjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jingang Zheng
Role: primary
Yan Wang
Role: primary
Zheng Zhang
Role: primary
Yingling Zhou
Role: primary
Jingfeng Wang
Role: primary
Yingling Zhou
Role: primary
Guixin He
Role: primary
Bei Shi
Role: primary
Yongjun Li
Role: primary
Xi Su
Role: primary
Xiaoyan Wang
Role: primary
Yijie Huang
Role: primary
Zeqi Zheng
Role: primary
Bin Liu
Role: primary
Shaobin Jia
Role: primary
Yanni Wang
Role: primary
Kang Yao
Role: primary
Yuxiang Dai
Role: backup
Xiangdong Xu
Role: primary
Wei Hu
Role: primary
Pengxiang Zheng
Role: primary
Xianxian Zhao
Role: primary
Chun Liang
Role: primary
Ben He
Role: primary
Shaowen Liu
Role: primary
Junfeng Zhang
Role: primary
Liuliu Feng
Role: primary
Chengxing Shen
Role: primary
Zening Shen
Role: primary
Yawei Xu
Role: primary
Xuebo Liu
Role: primary
Min Fan
Role: primary
Xuebin Han
Role: primary
Dengfeng Ma
Role: primary
Yin Liu
Role: primary
Xiaohong Liu
Role: primary
Jianan Wang
Role: primary
Guohui Zhang
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Wu R, Su Y, Liao J, Shen J, Ma Y, Gao W, Dong Z, Dai Y, Yao K, Ge J. Exome Sequencing Identified Susceptible Genes for High Residual Risks in Early-Onset Coronary Atherosclerotic Disease. Clin Cardiol. 2024 Dec;47(12):e70066. doi: 10.1002/clc.70066.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZS-CV-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.